Plain-English translation of NCT05966415 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether Endocalyx Pro, a food supplement, can help people with chronic heart failure manage excess fluid in their bodies. Heart failure often causes the body to retain too much salt and water, which makes symptoms worse. This study will compare the medication to a placebo (inactive pill) over 8 weeks to see if it reduces these fluids and improves how people feel.
People with heart failure struggle with fluid buildup, which causes swelling, shortness of breath, and reduces their quality of life. Current treatments don't work perfectly for everyone, so researchers want to test whether this medication might offer a new way to help the body get rid of excess salt and water.
If you join this study, you will take either the medication or a placebo — 4 capsules per day for 8 weeks — alongside your regular heart failure medicines. You can take the capsules in the morning and afternoon, or all at once in the morning, with or without food. The study will measure your blood pressure, body weight, fluid levels, blood work, and how much your symptoms have improved during regular clinic visits.
AI-generated summary from trial data · Aug 29, 2026 · Not medical advice
Netherlands